|
Volume
21 Number 6
30 June 2019
|
|
Home
>
Publications
>
Current
Neuro-Oncology >
Volume
21, Year 2019 >
Number 6, 30 June
|
|
|
|
|
|
Marafi F, Sasikumar A, Fathallah W, Esmail A.
18F-PSMA
1007 Brain PET/CT Imaging in Glioma Recurrence.
Clin
Nucl Med. 2019 Jun 1, 202045(1):e61-e62∟.
doi: 10.1097/RLU.0000000000002668∟.
PMID: 31162269∟.
Case report. ˍ
|
|
|
|
Wang S, Yao F, Lu X, Li Q, Su Z, Lee JH, Wang C, Du L.
Temozolomide promotes immune escape
of GBM cells via upregulating PD-L1.
Am J Cancer
Res. 2019 Jun 1, 2019;9(6):1161-1171∟.
PMID: 31285949∟.
Laboratory investigation. ˍ
|
|
|
|
Du XJ, Li XM, Cai LB, Sun JC, Wang SY, Wang XC, Pang XL, Deng ML,
Chen FF, Wang ZQ, Chen FR, Zhang HH, Wang HY, Piedra P, Chen ZP,
Lin J, Wu SX.
Efficacy and safety
of nimotuzumab in addition to radiotherapy and temozolomide for
cerebral glioblastoma: a phase II multicenter clinical trial.
J
Cancer. 2019 Jun 2, 2019;10(14):3214-3223∟.
doi: 10.7150/jca.30123∟.
PMID: 31289592∟.
Interventional study. ˍ
|
|
|
|
Jiang H, Zeng W, Ren X, Cui Y, Li M, Yang K, Elbaroody M, Lin S.
Super-early initiation of
temozolomide prolongs the survival of glioblastoma patients
without gross-total resection: a retrospective cohort study.
J
Neurooncol. 2019 Jun 7, 2019;144(1):127-135∟.
doi: 10.1007/s11060-019-03211-1∟.
PMID: 31175579∟.
Observational study. ˍ
|
|
|
|
Jairam V, Kann BH, Park HS, Miccio JA, Beckta JM, Yu JB, Prabhu
RS, Gao SJ, Mehta MP, Curran WJ, Bindra RS, Contessa JN, Patel KR.
Defining an Intermediate-risk Group
for Low-grade Glioma: A National Cancer Database
Analysis.
Anticancer Res. 2019 Jun 8,
2019;39(6):2911-2918∟.
doi: 10.21873/anticanres.13420∟.
PMID: 31177129∟.
Observational study. ˍ
|
|
|
|
Smith
CJ, Fairres MJ, Myers CS, Chapple KM, Klysik M, Karis JP, Youssef
E, Smith KA.
Long-term
outcome data from 121 patients treated with Gamma Knife
stereotactic radiosurgery as salvage therapy for focally recurrent
high-grade gliomas.
J
Radiosurg SBRT.
2019 [Jun 9];6(3):199-207∟.
PMID:
31998540∟.
Observational
study. ˍ
|
|
|
|
Alimohammadi E, Bagheri SR, Salehi AS, Rizevandi P, Rezaie Z, Abdi
A.
Prognostic factors in patients
with glioblastoma multiforme: focus on the pathologic
variants.
Acta Neurol Belg. 2019 Jun 20,
2020;120(6):1341-1350∟.
doi: 10.1007/s13760-019-01171-x∟.
PMID: 31222512∟.
Observational
study. ˍ
|
|
|
|
Tsang DS, Oliveira C, Bouffet E, Hawkins C, Ramaswamy V, Yee R,
Tabori U, Bartels U, Huang A, Millar BA, Crooks B, Bowes L, Zelcer
S, Laperriere N.
Repeat irradiation
for children with supratentorial high-grade glioma.
Pediatr
Blood Cancer. 2019 Jun 17, 2019;66(9):e27881∟.
doi: 10.1002/pbc.27881∟.
PMID: 31207154∟.
Observational
study. ˍ
|
|
|
|
Xia H, Zhong D, Wu X, Li J, Yang Y, Sun X.
Medulloblastomas
in cerebellopontine angle: Epidemiology, clinical manifestations,
imaging features, molecular analysis and surgical outcome.
J
Clin Neurosci. 2019 Jun 22, 2019;67:93-98∟.
doi: 10.1016/j.jocn.2019.06.013∟.
PMID: 31239198∟.
Observational
study. ˍ
|
|
|
|
Gupta T, Maitre M, Sastri GJ, Krishnatry R, Shirsat N, Epari S,
Sahay A, Chinnaswamy G, Patil V, Shetty P, Moiyadi A.
Outcomes
of salvage re-irradiation in recurrent medulloblastoma correlate
with age at initial diagnosis, primary risk-stratification, and
molecular subgrouping.
J Neurooncol. 2019 Jun 24,
2019;144(2):283-291∟.
doi: 10.1007/s11060-019-03225-9∟.
PMID: 31236820∟.
Observational
study. ˍ
|
|
|
|
Bleil CB, Bizzi JWJ, Bedin A, de Oliveira FH, Antunes ÁCM.
Survival and prognostic factors in
childhood medulloblastoma: A Brazilian single center experience
from 1995 to 2016.
Surg Neurol Int. 2019 Jun 25,
2019;10:120∟.
doi: 10.25259/SNI-237-2019∟.
PMID: 31528456∟.
Observational
study. ˍ
|
|
|
|
Chatzikonstantinou G, Ulrich P, Archavlis E, Zamboglou N,
Strouthos I, Zoga E, Baltas D, Tselis N.
Interstitial
high-dose-rate brachytherapy in the primary treatment of
inoperable glioblastoma multiforme.
J Contemp
Brachytherapy. 2019 Jun 28, 2019;11(3):215-220∟.
doi: 10.5114/jcb.2019.85722∟.
PMID: 31435428∟.
Observational
study. ˍ
|
|
|
|
|
|
|
|
|
